Originalartikel | erschienen - Druck | peer reviewed
Interaction among childhood trauma and functional polymorphisms in the serotonin pathway moderate the risk of depressive disorders.
Brain Imaging and Behavior
2014 ;
264 Suppl 1:
45 - 54
Bibliometrische Indikatoren
Impact Factor = 4,598
DOI = 10.1007/s00406-014-0536-2
PubMed-ID = 25214390
Autoren
Thompson P*, Stein J, Medland S, Hibar D, Vasquez A, Renteria M, Toro R, Jahanshad N, Schumann G, Franke B, Wright M, Martin N, Agartz I, Alda M, Alhusaini S, Almasy L, Almeida J, Alpert K, Andreasen N, Andreassen O, Apostolova L, Appel K1, Armstrong N, Aribisala B, Bastin M, Bauer M, Bearden C, Bergmann O, Binder E, Blangero J, Bockholt H, Bøen E, Bois C, Boomsma D, Booth T, Bowman I, Bralten J, Brouwer R, Brunner H, Brohawn D, Buckner R, Buitelaar J, Bulayeva K, Bustillo J, Calhoun V, Cannon D, Cantor R, Carless M, Caseras X, Cavalleri G, Chakravarty M, Chang K, Ching C, Christoforou A, Cichon S, Clark V, Conrod P, Coppola G, Crespo-Facorro B, Curran J, Czisch M, Deary I, de Geus E, den Braber A, Delvecchio G, Depondt C, de Haan L, de Zubicaray G, Dima D, Dimitrova R, Djurovic S, Dong H, Donohoe G, Duggirala R, Dyer T, Ehrlich S, Ekman C, Elvsåshagen T, Emsell L, Erk S, Espeseth T, Fagerness J, Fears S, Fedko I, Fernández G, Fisher S, Foroud T, Fox P, Francks C, Frangou S, Frey E, Frodl T, Frouin V, Garavan H, Giddaluru S, Glahn D, Godlewska B, Goldstein R, Gollub R, Grabe H1,2, Grimm O, Gruber O, Guadalupe T, Gur R, Göring H, Hagenaars S, Hajek T, Hall G, Hall J, Hardy J, Hartman C, Haß J, Hatton S, Haukvik U, Hegenscheid K3, Heinz A, Hickie I, Ho B, Hoehn D, Hoekstra P, Hollinshead M, Holmes A, Homuth G4, Hoogman M, Hong L, Hosten N3, Hottenga J, Hulshoff Pol H, Hwang K, Jack C, Jenkinson M, Johnston C, Jönsson E, Kahn R, Kasperaviciute D, Kelly S, Kim S, Kochunov P, Koenders L, Krämer B, Kwok J, Lagopoulos J, Laje G, Landen M, Landman B, Lauriello J, Lawrie S, Lee P, Le Hellard S, Lemaître H, Leonardo C, Li C, Liberg B, Liewald D, Liu X, Lopez L, Loth E, Lourdusamy A, Luciano M, Macciardi F, Machielsen M, Macqueen G, Malt U, Mandl R, Manoach D, Martinot J, Matarin M, Mather K, Mattheisen M, Mattingsdal M, Meyer-Lindenberg A, McDonald C, McIntosh A, McMahon F, McMahon K, Meisenzahl E, Melle I, Milaneschi Y, Mohnke S, Montgomery G, Morris D, Moses E, Mueller B, Muñoz Maniega S, Mühleisen T, Müller-Myhsok B, Mwangi B, Nauck M5, Nho K, Nichols T, Nilsson L, Nugent A, Nyberg L, Olvera R, Oosterlaan J, Ophoff R, Pandolfo M, Papalampropoulou-Tsiridou M, Papmeyer M, Paus T, Pausova Z, Pearlson G, Penninx B, Peterson C, Pfennig A, Phillips M, Pike G, Poline J, Potkin S, Pütz B, Ramasamy A, Rasmussen J, Rietschel M, Rijpkema M, Risacher S, Roffman J, Roiz-Santiañez R, Romanczuk-Seiferth N, Rose E, Royle N, Rujescu D, Ryten M, Sachdev P, Salami A, Satterthwaite T, Savitz J, Saykin A, Scanlon C, Schmaal L, Schnack H, Schork A, Schulz S, Schür R, Seidman L, Shen L, Shoemaker J, Simmons A, Sisodiya S, Smith C, Smoller J, Soares J, Sponheim S, Sprooten E, Starr J, Steen V, Strakowski S, Strike L, Sussmann J, Sämann P, Teumer A4, Toga A, Tordesillas-Gutierrez D, Trabzuni D, Trost S, Turner J, Van den Heuvel M, van der Wee N, van Eijk K, van Erp T, Van Haren N, van 't Ent D, van Tol M, Valdés Hernández M, Veltman D, Versace A, Völzke H6, Walker R, Walter H, Wang L, Wardlaw J, Weale M, Weiner M, Wen W, Westlye L, Whalley H, Whelan C, White T, Winkler A, Wittfeld K2, Woldehawariat G, Wolf C, Zilles D, Zwiers M, Thalamuthu A, Schofield P, Freimer N, Lawrence N, Drevets W
Beteiligte Einrichtungen
1 - Klinik und Poliklinik für Psychiatrie und Psychotherapie
2 - Deutsches Zentrum für Neurodegenerative Erkrankungen Rostock / Greifswald Teilstandort Greifswald
3 - Zentrum für Radiologie / Institut für Diagnostische Radiologie und Neuroradiologie
4 - Interfakultäres Institut für Genetik und Funktionelle Genomforschung / Abt. Funktionelle Genomforschung
5 - Institut für Klinische Chemie und Laboratoriumsmedizin
6 - Institut für Community Medicine / Abt. SHIP KEF
Abstract
Depressive disorders are influenced by a complex interplay between genetic and environmental factors. Multiple studies support a role of serotonergic pathways in the pathophysiology of depressive disorders. As a rate-limiting enzyme of serotonin synthesis in the brain, tryptophan hydroxylase 2 (TPH2) represents a plausible candidate gene. This also applies to the serotonin reuptake transporter (5-HTTLPR) regulating the availability of serotonin in the synaptic gap. We hypothesize that functional polymorphisms (TPH2: rs7305115, 5-HTTLPR and rs25531) within both genes contribute to the risk of depressive disorders after childhood abuse in adult life. To confirm our results, we investigated two independent samples of Caucasian subjects from the study of health in Pomerania (SHIP-LEGEND: n = 2,029 and SHIP-TREND-0: n = 2,475). Depression severity was assessed by the Beck depression inventory (BDI-II) for LEGEND and the patient health questionnaire (PHQ-9) for TREND-0. Childhood abuse was assessed by the childhood trauma questionnaire. Rs7305115 (TPH2) revealed significant effects in SNP × abuse and SNP × SNP as well as in the three-way interaction. This three-way interaction among abuse, TPH2 and 5-HTTLPR showed a significant effect on depression score (p = 0.023). The SS genotype of 5-HTTLPR was associated with increased depression scores after childhood abuse only in carriers of the low-expression TPH2 GG genotype, whereas the TPH2 AA genotype reversed this effect. Our results support the role of interaction effects of genetic variants within serotonergic pathways. Genetic variants that may decrease the presynaptic serotonin concentration were associated with increased adult depressive symptoms in subjects with childhood abuse.
Veröffentlicht in
Brain Imaging and Behavior
| Jahr | 2014 |
| Impact Factor (2014) | 4,598 |
| Volume | 264 Suppl 1 |
| Issue | |
| Seiten | 45 - 54 |
| Open Access | nein |
| Peer reviewed | ja |
| Artikelart | Originalartikel |
| Artikelstatus | erschienen - Druck |
| DOI | 10.1007/s00406-014-0536-2 |
| PubMed-ID | 25214390 |
Allgemeine Daten zur Fachzeitschrift
Kurzbezeichnung: BRAIN IMAGING BEHAV
ISSN: 1931-7557
eISSN: 1931-7565
Land: USA
Sprache: English
Kategorie(n):
Impact Factor Entwicklung
ISSN: 1931-7557
eISSN: 1931-7565
Land: USA
Sprache: English
Kategorie(n):
- MULTIDISCIPLINARY SCIENCES
Impact Factor Entwicklung
| Jahr | Impact Factor |
|---|---|
| 2009 | 1,044 |
| 2010 | 0,859 |
| 2011 | 1,661 |
| 2012 | 2,667 |
| 2013 | 3,385 |
| 2014 | 4,598 |
| 2015 | 3,667 |
| 2016 | 3,985 |
| 2017 | 3,719 |
| 2018 | 3,418 |
| 2019 | 3,391 |
| 2020 | 3,978 |
| 2021 | 3,224 |
| 2022 | 3,2 |
| 2023 | 2,4 |
| 2024 | 2,4 |
FAQs | Impressum | Datenschutz

